搜索临床试验以:Sintilimab 200mg MB07133 600mg
总计1414个结果
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial Groups (ENGOT); Myriad...主动,不招人复发性卵巢癌 | 铂类化疗完全或部分缓解后 | 白金敏感 | BRCA突变大韩民国, 法国, 中国, 意大利, 美国, 以色列, 英国, 加拿大, 日本, 德国, 巴西, 荷兰, 比利时, 波兰, 澳大利亚, 俄罗斯联邦, 西班牙
-
Lihir Medical CentreUniversity of Washington; World Health Organization; Barcelona Institute for Global Health; National...完全的
-
Hellenic Oncology Research Group终止
-
Chinese PLA General HospitalTianjin TongRenTang Group Co., Ltd.未知
-
Servier Bio-Innovation LLCInstitut de Recherches Internationales Servier尚未招聘具有 IDH1 突变、未经治疗或之前接受过 1 种全身治疗方案治疗的局部晚期或转移性传统软骨肉瘤
-
Neuroscience Trials AustraliaThe Florey Institute of Neuroscience and Mental Health主动,不招人
-
Norwegian University of Science and TechnologySt. Olavs Hospital完全的
-
Chong Kun Dang PharmaceuticalCholine Alfoscerate Re-evaluation Consortium (57 pharmaceutical companies)尚未招聘
-
Dr. Yannis RaftopoulosHeron Therapeutics招聘中
-
ANRS, Emerging Infectious Diseases尚未招聘
-
Sir Mortimer B. Davis - Jewish General HospitalCancer Research Network终止
-
Guangdong Raynovent Biotech Co., Ltd完全的
-
Sunnybrook Health Sciences CentreUnity Health Toronto完全的
-
Beth Israel Deaconess Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)招聘中
-
Eye & ENT Hospital of Fudan University招聘中